theendopedia

Omega-3 for endometriosis

Supplement

Last reviewed

Omega-3 has a split evidence picture. For primary dysmenorrhoea, multiple meta-analyses show moderate-to-large pain reduction with supplementation. For endometriosis specifically, a 2025 meta-analysis of 5 RCTs found no significant pain benefit — despite a clear reduction in inflammatory markers. The SAGE RCT (2020) in adolescents with endo actually found fish oil did slightly worse than placebo. Observational data suggests higher dietary omega-3 may lower endo risk. Low-risk and good for general health, but don't expect dramatic pain reduction. Typical effective doses in dysmenorrhoea trials: 300-1800mg EPA+DHA daily, with lower doses counterintuitively more effective.

Research status

Some Evidence

Endo-specific

Partial

Community signal

Mixed

How does Omega-3 work?

Omega-3 polyunsaturated fatty acids (EPA and DHA) work primarily by modifying prostaglandin and leukotriene metabolism: (1) EPA competes with arachidonic acid for the cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing pro-inflammatory series-2 prostaglandins (PGE2, PGF2α) and series-4 leukotrienes, shifting production toward less inflammatory series-3 prostaglandins. This is mechanistically parallel to how NSAIDs work, but upstream. (2) EPA and DHA are precursors to specialised pro-resolving mediators (resolvins, protectins, maresins) that actively resolve inflammation rather than just blocking it. (3) Reduction in pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) — confirmed in the Liu 2025 endo meta-analysis even though pain didn't improve. (4) Endometriosis-specific: EPA may attenuate NF-κB signaling in endometriotic lesions and reduce angiogenesis. The puzzle is why a mechanism that should help endo pain doesn't in RCTs — possibly because endo pain has central sensitisation and mechanical/neuropathic components that prostaglandin reduction alone doesn't address, whereas primary dysmenorrhoea is more purely prostaglandin-driven.

What does the research show about Omega-3 for endometriosis?

Below are studies linked to this intervention in our database, with design, quality, and outcomes summarised for quick scanning. Endo-specific evidence in this entry: Partial.

14 studies

  • The Role of Lifestyle and Diet in the Treatment of Endometriosis: A Review

    Boroncsok D et al. · 2026

    Systematic reviewEndometriosis-specificQuality: Medium

    2026 clinical review identifying omega-3 fatty acids among supplements with promising but variable evidence for endometriosis symptom relief, alongside vitamins C, D, E, magnesium, zinc, folate, NAC, curcumin, probiotics, and green tea polyphenols. Calls for larger well-designed trials.

    View publication

  • Effect of omega-3 polyunsaturated fatty acid on endometriosis

    Liu et al. · 2025

    Meta-analysisn=424Endometriosis-specificQuality: High

    Meta-analysis of 5 RCTs in endo patients. No significant effect on pain (MD -0.39, p=0.58), sexual activity, or quality of life scales. Did find significant reduction in inflammatory markers (MD -5.20, p<0.001). The most rigorous current assessment — concludes anti-inflammatory effect is real but pain effect is unclear.

    View publication

  • The Role of Nutrition in Endometriosis Prevention and Management: A Comprehensive Review

    Muharam R et al. · 2025

    Systematic reviewEndometriosis-specificQuality: Medium

    Recent comprehensive review of nutrition and endometriosis. Identifies omega-3 and omega-6 PUFAs among nutrients with promising anti-inflammatory and protective effects against endometriosis. Recommends balanced, nutritious diet rich in anti-inflammatory nutrients including omega-3 alongside limiting pro-inflammatory foods. Calls for personalised evidence-based recommendations.

    View publication

  • Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis

    Barrea L et al. · 2025

    Systematic reviewEndometriosis-specificQuality: Medium

    Review of medical nutrition therapy for endometriosis (focus on patients with comorbid obesity). Omega-3 fatty acids noted among supplements with promising anti-inflammatory and antioxidative effects in preclinical and clinical studies, alongside NAC, resveratrol, vitamins C and E, and probiotics. Mediterranean diet pattern identified as having strongest dietary pattern evidence.

    View publication

  • Diet associations in endometriosis: a critical narrative assessment with special reference to gluten

    Brouns F et al. · 2023

    Systematic reviewEndometriosis-specificQuality: Medium

    Critical narrative review from a Dutch group that challenges uncritical enthusiasm about diet-endo links. Notes that observed positive effects of omega-3 and other dietary components on endometriosis often disappear when adjusting for confounders (BMI), when translated to clinical endpoints, or when nutrients are part of mixed diets rather than isolated supplements. Important counterweight to enthusiasm.

    View publication

What do people in online endo communities say about Omega-3?

Community signals are indicative only — they reflect informal conversation in endometriosis-focused spaces. People posting may or may not have a formal diagnosis; this is not a substitute for clinical evidence or care.

Reddit

Mixed · 2,000 mentions

HealthUnlocked

Mixed · 600 mentions

  • “I've taken fish oil for two years. Honestly couldn't tell you if it does anything specific. Bloodwork shows my inflammation markers are lower than they were so I keep taking it.”

    — Reddit

  • “Switched from cheap supermarket fish oil to a high-EPA brand at 2000mg and noticed an actual difference within a couple of months. The dose matters, the cheap stuff is basically homeopathic.”

    — Reddit

  • “Vegan algae oil for me — same EPA/DHA without the fish burps. More expensive but worth it.”

    — Reddit

  • “Started omega-3 alongside changing my diet to be more Mediterranean. Genuinely think the combination has helped, hard to know which bit is doing what.”

    — HealthUnlocked

  • “My nutritionist had me on 2g EPA daily for inflammation. Six months in, slightly less bloating and joint pain, periods about the same.”

    — HealthUnlocked

  • “Tried it for six months, didn't notice anything, stopped. Not everything works for everyone.”

    — HealthUnlocked

How is Omega-3 typically used?

Practical notes

Effective doses in the positive dysmenorrhoea trials: 300-1800mg combined EPA+DHA daily, taken 2-3 months before expected benefit. Interesting finding from Mohammadi 2022: lower daily doses (~500mg) were MORE effective than higher doses (>1500mg). Starting point: 500-1000mg combined EPA+DHA (e.g. a single 1000mg fish oil capsule daily). For dedicated EPA/DHA content, read the label — a 1000mg fish oil capsule typically contains 180-300mg EPA and 120-200mg DHA, so check totals. Quality matters: look for molecularly distilled/purified forms with third-party testing for mercury and PCBs. Algae-based DHA+EPA is a vegetarian option. Take with fatty meals for better absorption. Side effects are mild: fishy burps (reduced with enteric-coated or phospholipid forms), occasional GI upset, mild anticoagulant effect (notable with doses >3g/day; caution if on anticoagulants). Avoid cod liver oil if pregnant (high vitamin A). Also provides background cardiovascular, cognitive, and general anti-inflammatory benefits independent of endo. Cost: £5-15/month.

What should you know before trying Omega-3?

The most important caveat is the divergence between dysmenorrhoea evidence (positive) and endo-specific evidence (null). Simply extrapolating from primary dysmenorrhoea to endometriosis appears not to work in RCTs — both Liu 2025 meta-analysis and the SAGE RCT (Nodler 2020) show no pain benefit over placebo, despite clear anti-inflammatory effects. The Brouns 2023 review notes that many reported diet-endo associations disappear after adjusting for confounders like BMI. Other considerations: high-dose omega-3 (>3g/day) may cause mild bleeding tendency; theoretical concern about oxidised fish oil becoming pro-inflammatory, so product quality matters; the dose-response finding from Mohammadi 2022 (lower doses more effective) is counterintuitive and suggests we don't fully understand optimal dosing yet.

Related interventions

Other interventions in our database that target similar symptoms or fall under the same category as Omega-3.

Back to all interventions